Kyle Mannion (@kylemannionhn) 's Twitter Profile
Kyle Mannion

@kylemannionhn

Head & Neck faculty in @VUMChealth Dept of Otolaryngology. Account partly run by staff at @VanderbiltENT. Appts: 615-322-6180. Cancer appts: 615-875-1193.

ID: 1056952428069879808

linkhttps://www.vanderbilthealth.com/billwilkerson/ calendar_today29-10-2018 16:54:30

104 Tweet

275 Followers

111 Following

VUMC Otolaryngology–Head and Neck Surgery (@vanderbiltent) 's Twitter Profile Photo

Congrats to our Head & Neck team and their providers who received the Excellence in Patient Experience Awards for exceptional service. Recipients were Drs. James Netterville James Netterville, Alexander Langerman Alexander Langerman (he/him) 🏳‍🌈🇺🇦🇺🇸, Kyle Mannion Kyle Mannion & Sarah Rohde Sarah Rohde

Congrats to our Head &amp; Neck team and their providers who received the Excellence in Patient Experience Awards for exceptional service. Recipients were Drs. James Netterville <a href="/NettervilleJim/">James Netterville</a>, Alexander Langerman <a href="/langermology/">Alexander Langerman (he/him) 🏳‍🌈🇺🇦🇺🇸</a>, Kyle Mannion <a href="/KyleMannionHN/">Kyle Mannion</a> &amp; Sarah Rohde <a href="/SarahLRohde/">Sarah Rohde</a>
VUMC Otolaryngology–Head and Neck Surgery (@vanderbiltent) 's Twitter Profile Photo

*Our department has acquired an SP (single port) surgical robot that will help provide more targeted and accurate transoral robotic surgery (TORS) for patients with head and neck cancer. Michael Topf MD, MSCI Kyle Mannion @emilystemb #Innovation #HeadAndNeckCancer news.vumc.org/2021/10/21/new…

*Our department has acquired an SP (single port) surgical robot that will help provide more targeted and accurate transoral robotic surgery (TORS) for patients with head and neck cancer. <a href="/TopfHNS/">Michael Topf MD, MSCI</a> <a href="/KyleMannionHN/">Kyle Mannion</a> @emilystemb #Innovation #HeadAndNeckCancer 
news.vumc.org/2021/10/21/new…
VUMC Otolaryngology–Head and Neck Surgery (@vanderbiltent) 's Twitter Profile Photo

This article by Emily Stembridge highlights the work of Dr. Netterville in helping inspire a generation of otolaryngologists and pays tribute to his many accomplishments as a humanitarian and surgeon. James Netterville AmAcadOtolaryngology #HeadAndNeckCancer #ENT news.vumc.org/2021/10/28/net…

American Journal of Otolaryngology (@amjotol) 's Twitter Profile Photo

Interesting new work which investigates a matter of concern to all clinicians - the pandemic is indeed resulting in advanced stage presentations, notably for head and neck cancer patients. Madelyn Stevens Michael Topf MD, MSCI VUMC Otolaryngology–Head and Neck Surgery #Covid_19 sciencedirect.com/science/articl…

VUMC Otolaryngology–Head and Neck Surgery (@vanderbiltent) 's Twitter Profile Photo

Many have worked to study the effects of Covid-19 on H&N #cancer patients & were able to conclude H&N mucosal SCC patients presented w/ more advanced clinical nodal disease during the early months of the COVID-19 pandemic despite no change in presenting symptoms.

Many have worked to study the effects of Covid-19 on H&amp;N #cancer patients &amp; were able to conclude H&amp;N mucosal SCC patients presented w/ more advanced clinical nodal disease during the early months of the COVID-19 pandemic despite no change in presenting symptoms.
VUMC Otolaryngology–Head and Neck Surgery (@vanderbiltent) 's Twitter Profile Photo

*Preoperative nivolumab +/- tadalafil is safe in head and neck squamous cell carcinoma and results in > 50% of the patients having a pTR of at least 20% after 4 weeks of treatment. Mr Gaurav Kumar ENT Nikita Kotlov Kyle Mannion Michael Gibson, MD PhD Vanderbilt University. James Netterville clincancerres.aacrjournals.org/content/early/…

*Preoperative nivolumab +/- tadalafil is safe in head and neck squamous cell carcinoma and results in &gt; 50% of the patients having a pTR of at least 20% after 4 weeks of treatment. <a href="/KumarENT_LONDON/">Mr Gaurav Kumar ENT</a>  <a href="/avkitex/">Nikita Kotlov</a> <a href="/KyleMannionHN/">Kyle Mannion</a> <a href="/mgibson21212/">Michael Gibson, MD PhD Vanderbilt University.</a> <a href="/NettervilleJim/">James Netterville</a> 
clincancerres.aacrjournals.org/content/early/…
VUMC Otolaryngology–Head and Neck Surgery (@vanderbiltent) 's Twitter Profile Photo

*Preoperative nivolumab +/- tadalafil is safe in head and neck squamous cell carcinoma and results in > 50% of the patients having a pTR of at least 20% after 4 weeks of treatment. Mr Gaurav Kumar ENT Nikita Kotlov Kyle Mannion Michael Gibson, MD PhD Vanderbilt University. James Netterville clincancerres.aacrjournals.org/content/early/…

*Preoperative nivolumab +/- tadalafil is safe in head and neck squamous cell carcinoma and results in &gt; 50% of the patients having a pTR of at least 20% after 4 weeks of treatment. <a href="/KumarENT_LONDON/">Mr Gaurav Kumar ENT</a>  <a href="/avkitex/">Nikita Kotlov</a> <a href="/KyleMannionHN/">Kyle Mannion</a> <a href="/mgibson21212/">Michael Gibson, MD PhD Vanderbilt University.</a> <a href="/NettervilleJim/">James Netterville</a> 
clincancerres.aacrjournals.org/content/early/…